Comments
Loading...

Actuate Therapeutics

ACTUNASDAQ
Logo brought to you by Benzinga Data
$8.00
-0.11-1.36%
At close: -
$7.70
-0.30-3.75%
After Hours: 7:03 AM EDT

Actuate Therapeutics (NASDAQ:ACTU) Stock Quotes, Forecast and News Summary

Actuate Therapeutics Stock (NASDAQ: ACTU) stock price, news, charts, stock research, profile.

Open$7.95
Close$8.00
Volume / Avg.10.16K / 57.52K
Day Range$7.69 - $8.48
52 Wk Range5.51 - 10.16
Market Cap$150.39M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
35
Short Interest-
Days to Cover1.09

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Open$7.95
Close$8.00
Volume / Avg.10.16K / 57.52K
Day Range$7.69 - $8.48
52 Wk Range5.51 - 10.16
Market Cap$150.39M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
35
Short Interest-
Days to Cover1.09

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ACTU
ZURA

FAQ

Q

How do I buy Actuate Therapeutics (ACTU) stock?

A

You can purchase shares of Actuate Therapeutics (NASDAQ:ACTU) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Actuate Therapeutics (ACTU) competitors?

Q

What is the forecast, or price target, for Actuate Therapeutics (ACTU) stock?

A

There is no analysis for Actuate Therapeutics to provide a consensus price target.

Q

What is the current price for Actuate Therapeutics (ACTU)?

A

The stock price for Actuate Therapeutics (NASDAQ: ACTU) is $8 last updated January 8, 2025 at 4:00 PM EST.

Q

Does Actuate Therapeutics (ACTU) pay a dividend?

A

There are no upcoming dividends for Actuate Therapeutics.

Q

When is Actuate Therapeutics (NASDAQ:ACTU) reporting earnings?

A

Actuate Therapeutics’s Q4 earnings are confirmed for Friday, February 21, 2025.

Q

Is Actuate Therapeutics (ACTU) going to split?

A

There is no upcoming split for Actuate Therapeutics.

Q

What sector and industry does Actuate Therapeutics (ACTU) operate in?

A

Actuate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch